## Abstract Without appropriately timed specimens, serological confirmation of congenital rubella infection may be a problem. We have compared the persistence of specific IgM and low avidity specific IgG~1~ in 141 sera from 120 cases of serologically confirmed congenital rubella infection with the
Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection
✍ Scribed by H. I. J. Thomas; Dr. P. Morgan-Capner; A. Roberts; L. Hesketh
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 425 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Between two and seven sera from cases of persistent detection of rubella‐specific IgM for periods in excess of 2.5 months, but in the absence of recent primary rubella or rubella reinfection, were examined for rheumatoid factor, heterophile antibody, and IgM reactivity against toxo‐plasma and a number of viruses. The relative avidity of the rubella‐specific lgG, has been assessed in all the sera by two methods.
None of the sera contained rheumatoid factor or heterophile antibody, nor did any contain detectable concentrations of IgM specific for any of the panel of antigens apart from five sera which contained low concentrations of IgM specific for some coxsackieviruses B. No sera were positive for low avidity specific IgG, although three did give equivocal results with one avidity test and one gave equivocal results with the second avidity test.
📜 SIMILAR VOLUMES
## Abstract Rubella‐specific IgM was measured in a single fraction of serum from a sucrose density gradient. Haemagglutination inhibition (HAI) tests were performed on paired aliquots of the fraction untreated and after treatment with 2‐mercaptoethanol, dilutions of the aliquots being incubated ove
The avidity (functional affinity) and titre of rubella-specific IgG antibodies were examined in sequential and cross-sectional sera from 38 adult HIV-infected patients, whose HIV status ranged from pre-and recent HIV seroconversion to the AIDS-related complex (ARC) and AIDS, in order to determine wh